RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
12.67
-0.56 (-4.23%)
At close: Jun 27, 2025, 4:00 PM
12.75
+0.08 (0.63%)
After-hours: Jun 27, 2025, 6:24 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $514.87 million as of June 27, 2025. Its market cap has decreased by -77.59% in one year.
Market Cap
514.87M
Enterprise Value
297.57M
1-Year Change
-77.59%
Ranking
Category
Stock Price
$12.67
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $514.87M, an increase of 21.34%. That is a compound annual growth rate of 5.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 537.63M | -61.20% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |